BioMarin Pharmaceutical (BMRN) P/FCF US GAAP (year values) |
||||||||
| 2022 | 2023 | 2024 | 2025 | LTM ? | ||||
| P/FCF | 349.0 | 289.5 | 26.3 | 15.7 | 13.6 | |||
| Changes by years, y/y, % | -100% | -17% | -91% | -40% | ||||
BioMarin Pharmaceutical. P/FCF
BioMarin Pharmaceutical. P/FCF, changes, %
BioMarin Pharmaceutical (BMRN) P/FCF US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| P/FCF | 21.8 | 15.2 | 12.5 | 15.7 | 14.2 | 13.6 | ||
| Changes by years, y/y, % | -78% | -79% | -72% | -40% | -35% | |||
| Changes by quarters, q/q, % | -17% | -30% | -18% | +26% | -10% | |||